The challenges and opportunities of protein and peptide commercialisation - @KTNUK's Dana Heldt explores '#directedevolution' and profiles some UK companies working in this space.
@labgeni_us @Zentraxa_Ltd @KTN_SynBioSIG @Biocats #synbio #biobased
Sunrise run through Glen Canyon Park to shake the jetlag and now ready for #SynBioBeta2018 Come say hello at the @SynbiCITE stand if you want the know about @BrisSynBio's world-class #synbio #research and supported companies @Zentraxa_Ltd @CYTOSEEK Imophoron and @VitamicaAMR
We are very proud to announce that @ziylo has been acquired by @novonordisk in a deal that could exceed USD$800m. This could lead to the development of a ground-breaking treatment for #diabetes patients, demonstrating the global impact of #Bristol science. https://t.co/mYpslKus26
The Unit DX June newsletter is now online. Featuring @Corr_Associates @Zentraxa_Ltd @kets_quantum @spinup_science @H_Destecroix @RoySocChem @bristoldc @insiderswest @davidclensy #SBT Read it and subscribe - https://t.co/1OwktYenCy